SLANGERUP DYREKLINIK ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About SLANGERUP DYREKLINIK ApS
SLANGERUP DYREKLINIK ApS (CVR number: 30905415) is a company from FREDERIKSSUND. The company recorded a gross profit of 541.4 kDKK in 2023. The operating profit was -73.4 kDKK, while net earnings were -59.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -9.4 %, which can be considered poor and Return on Equity (ROE) was -10.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 73.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. SLANGERUP DYREKLINIK ApS's liquidity measured by quick ratio was 3.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 621.69 | 621.06 | 676.36 | 661.08 | 541.36 |
EBIT | 111.93 | 184.46 | 117.71 | 138.12 | -73.37 |
Net earnings | 59.09 | 150.28 | 57.22 | 103.83 | -59.19 |
Shareholders equity total | 292.05 | 442.33 | 499.55 | 603.39 | 544.20 |
Balance sheet total (assets) | 562.48 | 664.76 | 595.98 | 822.52 | 738.18 |
Net debt | -24.45 | - 279.42 | - 174.15 | - 261.09 | - 138.85 |
Profitability | |||||
EBIT-% | |||||
ROA | 17.6 % | 31.7 % | 18.7 % | 19.5 % | -9.4 % |
ROE | 22.5 % | 40.9 % | 12.2 % | 18.8 % | -10.3 % |
ROI | 22.7 % | 47.0 % | 25.0 % | 25.0 % | -12.8 % |
Economic value added (EVA) | 83.65 | 134.80 | 75.38 | 92.43 | -73.10 |
Solvency | |||||
Equity ratio | 51.9 % | 66.5 % | 83.8 % | 73.4 % | 73.7 % |
Gearing | 32.0 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.9 | 2.8 | 5.3 | 3.4 | 3.1 |
Current ratio | 2.0 | 3.0 | 5.7 | 3.6 | 3.2 |
Cash and cash equivalents | 117.82 | 279.42 | 174.15 | 261.09 | 138.85 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BBB | BBB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.